List of Astex Pharmaceuticals patents | 8 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11058705 Drug formulations	Patent 11058705 was granted and assigned to Astex Pharmaceuticals on July, 2021 by the United States Patent and Trademark Office.	Astex Pharmaceuticals	Astex Pharmaceuticals	United States Patent and Trademark Office	11058705	July 13, 2021
‌ US Patent 9913856 Drug formulations	Patent 9913856 was granted and assigned to Astex Pharmaceuticals on March, 2018 by the United States Patent and Trademark Office.	Astex Pharmaceuticals	Astex Pharmaceuticals	United States Patent and Trademark Office	9913856	March 13, 2018
‌ US Patent 10456415 Oligonucleotide analogues incorporating 5-aza-cytosine therein	Patent 10456415 was granted and assigned to Astex Pharmaceuticals on October, 2019 by the United States Patent and Trademark Office.	Astex Pharmaceuticals	Astex Pharmaceuticals	United States Patent and Trademark Office	10456415	October 29, 2019
‌ US Patent 10933079 Oligonucleotide analogues incorporating 5-aza-cytosine therein	Patent 10933079 was granted and assigned to Astex Pharmaceuticals on March, 2021 by the United States Patent and Trademark Office.	Astex Pharmaceuticals	Astex Pharmaceuticals	United States Patent and Trademark Office	10933079	March 2, 2021
‌ US Patent 9480698 Oligonucleotide analogues incorporating 5-aza-cytosine therein	Patent 9480698 was granted and assigned to Astex Pharmaceuticals on November, 2016 by the United States Patent and Trademark Office.	Astex Pharmaceuticals	Astex Pharmaceuticals	United States Patent and Trademark Office	9480698	November 1, 2016
‌ US Patent 9358248 Oligonucleotide analogues incorporating 5-aza-cytosine therein	Patent 9358248 was granted and assigned to Astex Pharmaceuticals on June, 2016 by the United States Patent and Trademark Office.		Astex Pharmaceuticals	United States Patent and Trademark Office	9358248	June 7, 2016
‌ US Patent 10517886 Drug formulations	Patent 10517886 was granted and assigned to Astex Pharmaceuticals on December, 2019 by the United States Patent and Trademark Office.	Astex Pharmaceuticals	Astex Pharmaceuticals	United States Patent and Trademark Office	10517886	December 31, 2019
‌ US Patent 9381207 Drug formulations	Patent 9381207 was granted and assigned to Astex Pharmaceuticals on July, 2016 by the United States Patent and Trademark Office.		Astex Pharmaceuticals	United States Patent and Trademark Office	9381207	July 5, 2016